| Differential oestrogen receptor binding is associated with clinical outcome in breast cancer CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ... Nature 481 (7381), 389-393, 2012 | 2027 | 2012 |
| Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ... Annals of oncology 25 (8), 1536-1543, 2014 | 825 | 2014 |
| The single-cell pathology landscape of breast cancer HW Jackson, JR Fischer, VRT Zanotelli, HR Ali, R Mechera, SD Soysal, ... Nature 578 (7796), 615-620, 2020 | 669 | 2020 |
| Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study HR Ali, L Chlon, PDP Pharoah, F Markowetz, C Caldas PLoS medicine 13 (12), e1002194, 2016 | 558 | 2016 |
| Prognostic and predictive value of PDL1 expression in breast cancer R Sabatier, P Finetti, E Mamessier, J Adelaide, M Chaffanet, HR Ali, ... Oncotarget 6 (7), 5449, 2015 | 539 | 2015 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6 (1), 8760, 2015 | 508 | 2015 |
| Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ... Science translational medicine 4 (157), 157ra143-157ra143, 2012 | 466 | 2012 |
| Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ... Cell reports 3 (2), 342-349, 2013 | 403 | 2013 |
| PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes HR Ali, SE Glont, FM Blows, E Provenzano, SJ Dawson, B Liu, L Hiller, ... Annals of Oncology 26 (7), 1488-1493, 2015 | 326 | 2015 |
| Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ... Nature 567 (7748), 399-404, 2019 | 309 | 2019 |
| Genome-driven integrated classification of breast cancer validated in over 7,500 samples HR Ali, OM Rueda, SF Chin, C Curtis, MJ Dunning, SAJR Aparicio, ... Genome biology 15, 1-14, 2014 | 243 | 2014 |
| Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer HR Ali, HW Jackson, VRT Zanotelli, E Danenberg, JR Fischer, H Bardwell, ... Nature Cancer 1 (2), 163-175, 2020 | 242 | 2020 |
| Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome G Friedman, O Levi-Galibov, E David, C Bornstein, A Giladi, M Dadiani, ... Nature Cancer 1 (7), 692-708, 2020 | 207 | 2020 |
| Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ... Scientific reports 6 (1), 1-13, 2016 | 195 | 2016 |
| BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells WT Khaled, S Choon Lee, J Stingl, X Chen, H Raza Ali, OM Rueda, ... Nature communications 6 (1), 5987, 2015 | 168 | 2015 |
| ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ... EMBO molecular medicine 3 (3), 167-180, 2011 | 142 | 2011 |
| Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance HR Ali, SJ Dawson, FM Blows, E Provenzano, PD Pharoah, C Caldas Breast Cancer Research 13, 1-15, 2011 | 137 | 2011 |
| Breast tumor microenvironment structures are associated with genomic features and clinical outcome E Danenberg, H Bardwell, VRT Zanotelli, E Provenzano, SF Chin, ... Nature genetics 54 (5), 660-669, 2022 | 128 | 2022 |
| The genomic and immune landscapes of lethal metastatic breast cancer L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ... Cell reports 27 (9), 2690-2708. e10, 2019 | 112 | 2019 |
| Biological and prognostic associations of miR‐205 and let‐7b in breast cancer revealed by in situ hybridization analysis of micro‐RNA expression in arrays of … JL Quesne, J Jones, J Warren, SJ Dawson, HR Ali, H Bardwell, F Blows, ... The Journal of pathology 227 (3), 306-314, 2012 | 94 | 2012 |
Carlos CaldasUniversity of Cambridge在 cruk.cam.ac.uk 的电子邮件经过验证
